Clinically driven design of multi-scale cancer models: the ContraCancrum project paradigm.
about
Integrating Multiscale Modeling with Drug Effects for Cancer TreatmentIntegrated PK-PD and agent-based modeling in oncologySemantic biomedical resource discovery: a Natural Language Processing framework.Differentiation resistance through altered retinoblastoma protein function in acute lymphoblastic leukemia: in silico modeling of the deregulations in the G1/S restriction point pathway.In Silico Oncology: Quantification of the In Vivo Antitumor Efficacy of Cisplatin-Based Doublet Therapy in Non-Small Cell Lung Cancer (NSCLC) through a Multiscale Mechanistic ModelSimulating radiotherapy effect in high-grade glioma by using diffusive modeling and brain atlasesPatient-specific modelling in drug design, development and selection including its role in clinical decision-making.From base pair to bedside: molecular simulation and the translation of genomics to personalized medicine.E-Science technologies in a workflow for personalized medicine using cancer screening as a case study.The standardized histogram shift of t2 magnetic resonance image (MRI) signal intensities of nephroblastoma does not predict histopathological diagnostic information.The Virtual Physiological Human.A study on the predictability of acute lymphoblastic leukaemia response to treatment using a hybrid oncosimulator.Clinical implications of in silico mathematical modeling for glioblastoma: a critical review.Molecular dynamics simulation reveals structural and thermodynamic features of kinase activation by cancer mutations within the epidermal growth factor receptor.
P2860
Q26770510-D8784484-9E0C-4854-9781-12860FF847BCQ27006577-77CB13D0-916A-45A9-8D35-9FB844E20E45Q35794224-7C5F3357-E2C9-4AD2-9400-B0F6FCBD5BF2Q35942281-AF80CC87-C2C6-45B9-B9B8-7236999DC39AQ36140933-A282790C-0BE8-4364-8F97-C01874798E99Q36316397-03548087-B6F1-4E43-8C00-7C7BF816565FQ38024134-C8DEE376-2F1B-40F9-9E0F-006EE70316A6Q38035239-67C503A7-E347-472F-B2AD-E3FB0C3225C3Q38371172-72C4910F-FFF0-47FA-80BB-71446C63AA82Q40608588-99EB2126-4B19-43FD-A6B6-D8D3CE4BF700Q45798565-D303781F-B8AE-4447-AA4C-2FDDBDA4C67CQ47236511-EA1D8949-51BD-4E87-A76A-1D8618EBCE5FQ47627726-6FE6C5FD-A594-4DBB-AF32-BCAB8FA96D6CQ54577949-32C46F5C-6F78-4E8C-8941-23FED80D03E0
P2860
Clinically driven design of multi-scale cancer models: the ContraCancrum project paradigm.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Clinically driven design of mu ...... ontraCancrum project paradigm.
@ast
Clinically driven design of mu ...... ontraCancrum project paradigm.
@en
type
label
Clinically driven design of mu ...... ontraCancrum project paradigm.
@ast
Clinically driven design of mu ...... ontraCancrum project paradigm.
@en
prefLabel
Clinically driven design of mu ...... ontraCancrum project paradigm.
@ast
Clinically driven design of mu ...... ontraCancrum project paradigm.
@en
P2093
P2860
P50
P356
P1433
P1476
Clinically driven design of multi-scale cancer models: the ContraCancrum project paradigm
@en
P2093
A N Haidar
A Roniotis
D Dionysiou
E Kolokotroni
G Clapworthy
G Stamatakos
P2860
P304
P356
10.1098/RSFS.2010.0037
P577
2011-03-30T00:00:00Z